Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)
China · Delayed Price · Currency is CNY 8.53
+0.43 (5.31%)
Sep 14, 2026, 3:00 PM CST
SHA:600613 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 480.49 | 594.09 | 779.39 | 715.28 | 656.49 | 493.8 |
Short-Term Investments | - | 80.75 | - | - | - | - |
Trading Asset Securities | 227.8 | 110.4 | 20.87 | 20.9 | - | - |
Cash & Short-Term Investments | 708.29 | 785.24 | 800.27 | 736.17 | 656.49 | 493.8 |
Cash Growth | -1.84% | -1.88% | 8.71% | 12.14% | 32.95% | 2.56% |
Accounts Receivable | 507.81 | 642.7 | 529.62 | 750.25 | 813.82 | 675.75 |
Other Receivables | 10.33 | 8.9 | 4.8 | 9.74 | 11.09 | 20.38 |
Receivables | 518.14 | 651.6 | 534.42 | 759.99 | 824.91 | 696.12 |
Inventory | 206.76 | 197.5 | 228.34 | 242.86 | 218.82 | 205.13 |
Other Current Assets | 25.91 | 19.57 | 32.88 | 33.23 | 69.67 | 50.8 |
Total Current Assets | 1,459 | 1,654 | 1,596 | 1,772 | 1,770 | 1,446 |
Property, Plant & Equipment | 995.12 | 1,031 | 1,054 | 1,052 | 1,100 | 1,167 |
Long-Term Investments | 74.33 | 86.19 | 87.02 | 74.14 | 67.33 | 83.08 |
Goodwill | 243.85 | 243.85 | 243.85 | 243.85 | 299.06 | 299.06 |
Other Intangible Assets | 91.87 | 93.3 | 96.65 | 95.2 | 98.91 | 104.81 |
Long-Term Deferred Tax Assets | 27.28 | 25.22 | 23.17 | 23.44 | 36.02 | 28.83 |
Long-Term Deferred Charges | 2.04 | 2.33 | 1.64 | 1.63 | 1.85 | 2.3 |
Other Long-Term Assets | 8.77 | 9.46 | 13.21 | 16.66 | 12.85 | 18.13 |
Total Assets | 2,902 | 3,145 | 3,116 | 3,279 | 3,386 | 3,149 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 231.88 | 241.9 | 223.85 | 249.85 | 186.8 | 188.31 |
Accrued Expenses | 14.3 | 34.38 | 29.21 | 31.98 | 49.76 | 25.89 |
Short-Term Debt | 40 | 61.91 | 27.03 | 18 | 21.08 | 2.72 |
Current Portion of Long-Term Debt | 8.34 | 38.28 | 40.74 | 36.92 | 35.68 | 36 |
Current Portion of Leases | - | 8.39 | 9.33 | 11.02 | 8.66 | 15.74 |
Current Income Taxes Payable | 15.21 | 4.34 | 5.11 | 2.24 | 7.9 | 10.04 |
Current Unearned Revenue | 37.29 | 35.58 | 35.4 | 29.67 | 82.83 | 45.06 |
Other Current Liabilities | 149.32 | 196.04 | 160.21 | 306.36 | 381.62 | 156.04 |
Total Current Liabilities | 496.34 | 620.82 | 530.88 | 686.04 | 774.34 | 479.81 |
Long-Term Debt | - | 88.56 | 129.58 | 170.1 | 207.7 | 242.9 |
Long-Term Leases | 7.18 | 12.35 | 10.45 | 17.03 | 12.48 | 14.92 |
Long-Term Unearned Revenue | 8.38 | 8.84 | 1.65 | 1.26 | 1.53 | 3.02 |
Long-Term Deferred Tax Liabilities | 14.26 | 17.02 | 16.45 | 14.34 | 18.24 | 15.81 |
Total Liabilities | 526.17 | 747.59 | 689.01 | 888.77 | 1,014 | 756.45 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 534.07 | 534.07 | 534.07 | 534.07 | 534.07 | 534.07 |
Additional Paid-In Capital | 968.99 | 968.99 | 968.99 | 968.99 | 968.99 | 968.99 |
Retained Earnings | 771.95 | 787.37 | 829.24 | 811.25 | 807.79 | 813.1 |
Comprehensive Income & Other | 20.79 | 29.9 | 30.74 | 21.07 | 16.26 | 28.12 |
Total Common Equity | 2,296 | 2,320 | 2,363 | 2,335 | 2,327 | 2,344 |
Minority Interest | 80.4 | 77.2 | 63.77 | 55.18 | 44.73 | 48.23 |
Shareholders' Equity | 2,376 | 2,398 | 2,427 | 2,391 | 2,372 | 2,393 |
Total Liabilities & Equity | 2,902 | 3,145 | 3,116 | 3,279 | 3,386 | 3,149 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 55.53 | 209.49 | 217.13 | 253.07 | 285.61 | 312.28 |
Net Cash (Debt) | 652.76 | 575.75 | 583.14 | 483.11 | 370.88 | 181.52 |
Net Cash Growth | 24.18% | -1.27% | 20.71% | 30.26% | 104.32% | -4.07% |
Net Cash Per Share | 1.19 | 1.05 | 1.06 | 0.93 | 0.69 | 0.34 |
Filing Date Shares Outstanding | 454.07 | 534.07 | 534.07 | 534.07 | 534.07 | 534.07 |
Total Common Shares Outstanding | 454.07 | 534.07 | 534.07 | 534.07 | 534.07 | 534.07 |
Working Capital | 962.76 | 1,033 | 1,065 | 1,086 | 995.55 | 966.05 |
Book Value Per Share | 5.06 | 4.34 | 4.42 | 4.37 | 4.36 | 4.39 |
Tangible Book Value | 1,960 | 1,983 | 2,023 | 1,996 | 1,929 | 1,940 |
Tangible Book Value Per Share | 4.32 | 3.71 | 3.79 | 3.74 | 3.61 | 3.63 |
Buildings | - | 1,091 | 1,002 | 1,001 | 1,001 | 978.49 |
Machinery | - | 709.05 | 651.9 | 651.59 | 643.1 | 607.56 |
Construction In Progress | - | 41.3 | 141.25 | 63.95 | 53.83 | 58.26 |